--- title: Buy Generic Sustiva Efavirenz 200mg 600mg Pills Online description: Sustiva (Efavirenz) 200mg/600mg Pills is an antiretroviral treatment for HIV infection. Order this trusted medication from our secure pharmacy. type: product language: en url: https://liabilis.com/order-sustiva-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 158.99 price_max: 1538.99 currency: USD offers: - name: 200mg x 30 pills price: 158.99 - name: 200mg x 60 pills price: 279.18 - name: 200mg x 90 pills price: 393.03 - name: 200mg x 120 pills price: 475.99 - name: 600mg x 30 pills price: 357.99 - name: 600mg x 60 pills price: 616.54 - name: 600mg x 90 pills price: 854.99 - name: 600mg x 120 pills price: 1082.99 - name: 600mg x 180 pills price: 1538.99 --- # Buy Generic Sustiva Efavirenz 200mg 600mg Pills Online Sustiva contains Efavirenz, a non-nucleoside reverse transcriptase inhibitor developed as part of HIV treatment regimens. It is used in combination with other antiretroviral agents to manage HIV infection by reducing viral load and increasing CD4 cell counts. This medication is designed for adults living with HIV who require effective viral suppression. Our pharmacy offers reliable access to Sustiva in 200mg and 600mg pill strengths for comprehensive HIV management. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **200mg** | 30 pills | **$158.99** | $5.31 | In Stock | | **200mg** | 60 pills | **$279.18** | $4.65 | In Stock | | **200mg** | 90 pills | **$393.03** | $4.37 | In Stock | | **200mg** | 120 pills | **$475.99** | $3.97 | In Stock | | **600mg** | 30 pills | **$357.99** | $11.94 | In Stock | | **600mg** | 60 pills | **$616.54** | $10.28 | In Stock | | **600mg** | 90 pills | **$854.99** | $9.50 | In Stock | | **600mg** | 120 pills | **$1082.99** | $9.03 | In Stock | | **600mg** | 180 pills | **$1538.99** | $8.55 | In Stock | [Buy Now](https://liabilis.com/order-sustiva-online-en.html) ## Introduction Sustiva is a tablet formulation that contains the active antiretroviral agent efavirenz. It is supplied as a pill in 200 mg and 600 mg strengths and belongs to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class. Sustiva is indicated for use in combination regimens that treat human immunodeficiency virus type 1 (HIV-1) infection in adults. It may also be incorporated into fixed-dose combinations for simplified dosing. ## Quick Reference Facts **Active Ingredient** : Efavirenz **Form** : Pill - 200 mg, 600 mg **Primary Uses** : Treatment of HIV-1 infection (as part of combination antiretroviral therapy) ## What is Sustiva? Sustiva is the generic version of medications containing the active compound efavirenz. Efavirenz is the core component of several branded antiretroviral products, most notably the brand-name tablets marketed under names such as Sustiva and Stocrin. As a generic, Sustiva provides the same therapeutic effect as its branded counterparts while offering a lower-cost alternative. The medication is manufactured by licensed pharmaceutical firms that meet international quality standards, although the specific manufacturer varies by market. ## How Sustiva Works Efavirenz belongs to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class. Reverse transcriptase is an enzyme that HIV uses to convert its RNA genome into DNA, a step essential for viral replication inside host cells. Efavirenz binds directly to a hydrophobic pocket of the reverse transcriptase enzyme, inducing a conformational change that blocks the enzyme’s activity. This inhibition prevents the synthesis of viral DNA, halting the replication cycle and reducing the amount of virus in the bloodstream. After oral administration, efavirenz is rapidly absorbed, reaching peak plasma concentrations within 3-5 hours. It is extensively metabolized by hepatic cytochrome P450 3A4 (CYP3A4) and CYP2B6, and its elimination half-life averages 40-55 hours, allowing once-daily dosing. ## Conditions Treated with Sustiva - **HIV-1 infection (adult patients)** - Efavirenz is combined with two nucleoside reverse transcriptase inhibitors (NRTIs) to achieve durable viral suppression. By blocking reverse transcription, it reduces plasma viral load and helps restore immune function. - **Fixed-dose combination regimens** - When co-formulated with NRTIs (e.g., emtricitabine and tenofovir), efavirenz provides a single-tablet regimen that simplifies adherence while delivering the same antiviral potency. ## Is Sustiva the Right Medication for You? Sustiva is appropriate for adult patients with confirmed HIV-1 infection who require a potent NNRTI as part of a three-drug regimen. It is especially useful for individuals who prefer once-daily dosing and who have no contraindications to efavirenz. Patients with baseline central nervous system (CNS) disorders, active psychiatric illness, or a history of severe hypersensitivity to efavirenz should discuss alternatives with their provider. Women who are pregnant or may become pregnant must be counseled about the known fetal risks; in many jurisdictions efavirenz-containing regimens are avoided during the first trimester. Additionally, patients with moderate to severe hepatic impairment require dose adjustment or close monitoring. ## Buying Sustiva from [our online pharmacy](https://liabilis.com/order-sustiva-online-en.html) ### Why Choose Our Service? Access to affordable, high-quality efavirenz can be difficult through conventional channels. [our online pharmacy](https://liabilis.com/order-sustiva-online-en.html) bridges that gap, offering a reliable source for Sustiva at prices close to wholesale cost. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every shipment is fulfilled by a pharmacy that operates under recognized regulatory frameworks, guaranteeing that the tablets meet stringent potency and purity standards. ### Pricing & Access Because Sustiva is a generic product, it is substantially less expensive than branded alternatives such as Sustiva or Stocrin. Our pricing model passes the cost savings directly to you, making long-term HIV therapy more financially sustainable. ### Discreet Delivery Orders are packaged in unmarked, tamper-evident envelopes and dispatched via secure courier services. Express delivery typically arrives within 7 days, while standard airmail reaches most destinations in approximately three weeks, preserving privacy throughout the process. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing**: Adults usually receive one 600 mg tablet once daily on an empty stomach (at least 1 hour before or 2 hours after a meal). For patients requiring dose reduction due to drug interactions or hepatic impairment, a 200 mg tablet may be substituted under physician guidance. - **Missed dose**: If a dose is forgotten and it has been less than 12 hours since the scheduled time, take the missed tablet immediately. Skip the dose if more than 12 hours have elapsed, and resume the regular schedule the following day. Do not double-dose. - **Overdose**: Suspected overdose should be treated as a medical emergency. Contact local emergency services or a poison-control center. Symptoms may include severe dizziness, vomiting, or CNS depression. - **Practical precautions**: Take Sustiva with water, avoiding grapefruit juice which can increase plasma concentrations. Do not consume alcohol excessively, as both substances may amplify CNS side effects. Refrain from operating heavy machinery until you know how the medication affects you. ## Safety Information ### ⚠️ Who Should Not Take Sustiva - Known hypersensitivity to efavirenz or any tablet excipients. - Patients with severe hepatic impairment (Child-Pugh class C) unless medically supervised. - Pregnant women in the first trimester, unless the benefits outweigh the risks as determined by a specialist. ### Common Side Effects - **Central nervous system**: Dizziness, insomnia, vivid dreams, headache (usually transient). - **Gastrointestinal**: Nausea, mild abdominal discomfort. - **Dermatologic**: Rash, which may be pruritic but typically resolves spontaneously. Management strategies include taking the tablet at bedtime, staying hydrated, and reporting persistent or worsening symptoms to a healthcare professional. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe skin reactions**: Stevens-Johnson syndrome or toxic epidermal necrolysis. - **Hepatotoxicity**: Jaundice, dark urine, elevated liver enzymes. - **Neuropsychiatric events**: Depression, suicidal ideation, hallucinations, or severe anxiety. If any of these occur, discontinue the medication and obtain emergency medical attention. ### Drug & Food Interactions - **CYP3A4 inducers** (e.g., rifampin, carbamazepine, St. John’s wort) → ↓ efavirenz levels, possible loss of efficacy. - **CYP3A4 inhibitors** (e.g., ketoconazole, azole antifungals) → ↑ efavirenz concentrations, heightened CNS toxicity. - **Protease inhibitors** (e.g., ritonavir) → May require dose adjustment. - **Anticonvulsants** (e.g., phenytoin) → Reduced efavirenz exposure. - **Alcohol** → Exacerbates CNS side effects; limiting intake is advisable. ## Off-Label and Investigational Uses of Sustiva - **Pre-exposure prophylaxis (PrEP)**: Some clinical studies have evaluated efavirenz-containing regimens for HIV prevention, but regulatory agencies have not approved this indication. - **Mother-to-child transmission**: Efavirenz has been investigated as part of combination therapy to reduce vertical transmission; guidelines currently favor alternative agents due to teratogenic concerns. - **Neurocognitive disorder research**: Early-phase trials have explored efavirenz’s impact on HIV-associated neurocognitive impairment. These investigations remain experimental, and use outside approved indications should occur only under specialist supervision. ## Storage & Handling - Store tablets at 20 °C - 25 °C (68 °F - 77 °F). - Keep the container tightly closed, protected from moisture and light. - Do not freeze. - Discard any tablets that are discolored or past their expiration date. - Follow local regulations for pharmaceutical waste when disposing of unused medication. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Sustiva tablets?** Yes, but you should carry the medication in its original labeled container and have a copy of your prescription or a physician’s letter to present to customs officials if requested. - **Will grapefruit juice affect my Sustiva therapy?** Grapefruit juice can inhibit CYP3A4 enzymes, potentially raising efavirenz levels and increasing the risk of CNS side effects. It is safest to avoid grapefruit products while taking this medication. - **Is it safe to take Sustiva with a high-protein meal?** Efavirenz absorption is reduced when taken with food, especially meals high in fat or protein. The recommended administration is on an empty stomach to achieve consistent drug exposure. **Product & Formulation Details** - **What do Sustiva tablets look like?** The 200 mg tablet is typically white, oval-shaped, and film-coated; the 600 mg tablet is larger, round, and also film-coated. Exact appearance may vary slightly by manufacturer. - **Can I split a Sustiva tablet?** Sustiva tablets are not scored, and splitting may result in uneven dosing. Only split tablets if a healthcare professional explicitly advises it. **Regulatory & Safety Nuances** - **Will Sustiva show up on a standard drug test?** Efavirenz is not typically screened for in routine employment drug tests, which focus on substances such as opioids, amphetamines, cocaine, cannabis, and benzodiazepines. - **Is Sustiva approved for use in patients over 65?** Efavirenz is approved for adults of all ages, but older patients may have higher susceptibility to CNS effects and should be monitored closely. - **How does Sustiva affect athletic doping tests?** Efavirenz is not listed as a prohibited substance by major anti-doping agencies; however, athletes should disclose all medications to their team physician. **Scientific & Clinical Curiosity** - **When was efavirenz first approved for HIV treatment?** Efavirenz received its first regulatory approval in the United States in 1998 as part of combination antiretroviral therapy. - **How does efavirenz differ from other NNRTIs like nevirapine?** Efavirenz has a longer half-life, allowing once-daily dosing, whereas nevirapine typically requires twice-daily administration and carries a higher risk of severe skin reactions. - **What is the significance of the 600 mg dose?** The 600 mg strength provides the standard once-daily exposure needed for viral suppression in most patients, as established by pivotal clinical trials. ## Glossary **Non-nucleoside reverse transcriptase inhibitor (NNRTI)** : A class of antiretroviral drugs that bind directly to HIV reverse transcriptase, causing a conformational change that blocks the enzyme’s activity. **Half-life** : The time required for the plasma concentration of a drug to decrease by 50 %. For efavirenz, this is approximately 40-55 hours, supporting once-daily dosing. **Stevens-Johnson syndrome** : A rare, severe skin reaction characterized by widespread blistering and epidermal detachment, requiring immediate medical intervention. ## Disclaimer The information provided about **Sustiva** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-sustiva-online-en.html) offers access to **Sustiva** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.